Back to Search
Start Over
PB2122: A PHASE 1/2 MULTI-CENTER, DOSE-FINDING STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PK AND EFFICACY OF ZN-D5, A NOVEL BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS
- Source :
- HemaSphere, Vol 7, p e5544426 (2023)
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 7
- Database :
- Directory of Open Access Journals
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.26f7d0a2807f4bd8a3517867b2bca6a2
- Document Type :
- article
- Full Text :
- https://doi.org/10.1097/01.HS9.0000975252.55444.26